Dexrazoxane (Breckenridge Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Dexrazoxane drug offered from Breckenridge Pharmaceutical, Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Breckenridge Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Dexrazoxane Hydrochloride |
SUBSTANCE NAME: | DEXRAZOXANE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-05 |
END MARKETING DATE: | 0000-00-00 |
Dexrazoxane HUMAN PRESCRIPTION DRUG Details:
Item Description | Dexrazoxane from Breckenridge Pharmaceutical, Inc. |
LABELER NAME: | Breckenridge Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 500(mg/50mL) |
START MARKETING DATE: | 2016-12-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51991-942_46cc35ce-76d6-473e-a0bf-24d973c20791 |
PRODUCT NDC: | 51991-942 |
APPLICATION NUMBER: | ANDA207321 |
Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: